Clinical Trial Update: Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV [EARLY_Phase 1]

View source ↗

Summary

This update covers an early-phase Phase 1 trial of RD06-04, a targeted CD19 universal CAR-T cell therapy, for idiopathic inflammatory myopathy and ANCA-associat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Idiopathic Inflammatory Myopathy

Drugs mentioned

• RD06-04 Targeted CD19 Universal CAR-T Cell Injection

Snippet

Sponsor: Peking University People's Hospital | Conditions: Idiopathic Inflammatory Myopathies, ANCA-Associated Vasculitis | EARLY_Phase 1 | Status: NOT_YET_RECRUITING